Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.91 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 11/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.47 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 4/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.43 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.43 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL10552280 | 1.00 | LMNA (0.91) | LMNAHSD17B10ALOX15TSHRALDH1A1 | |
| Acrylic Acid SCHEMBL8377395 | 1.00 | LMNA (0.91) | LMNAHSD17B10ALOX15TSHRALDH1A1 | |
| Acrylic Acid SCHEMBL27399375 | 1.00 | LMNA (0.91) | LMNAHSD17B10ALOX15TSHRALDH1A1 | |
| Acrylic Acid SCHEMBL28280279 | 1.00 | LMNA (0.91) | LMNAHSD17B10ALOX15TSHRALDH1A1 | |
| Acrylic Acid SCHEMBL8852653 | 1.00 | — | — | |
| Acrylic Acid SCHEMBL56459 | 1.00 | — | — | |
| Acrylic Acid SCHEMBL6322904 | 1.00 | — | — | |
| Acrylic Acid SCHEMBL5088209 | 1.00 | LMNA (0.91) | LMNAHSD17B10ALOX15TSHRALDH1A1 | |
| Acrylic Acid SCHEMBL9766309 | 0.96 | — | — | |
| Acrylic Acid SCHEMBL7778846 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104869973-B | Slurry Powder cosmetic compositions and method | 雅诗兰黛国际公司 | 2019-03-01 | — | — | CN | claimed |
| EP-2962682-B1 | METHOD OF MAKING A CONTACT LENS DRUG DELIVERY DEVICE | MASSACHUSETTS INST TECHNOLOGY (US) | 2018-03-28 | — | — | EP | claimed |
| EP-2962682-A1 | CONTACT LENS DRUG DELIVERY DEVICE | Massachusetts Institute Of Technology (US) | 2016-01-06 | — | — | EP | claimed |
| EP-2370054-B1 | CONTACT LENS DRUG DELIVERY DEVICE | MASSACHUSETTS INST TECHNOLOGY (US) | 2015-10-07 | — | — | EP | claimed |
| EP-2370054-A2 | CONTACT LENS DRUG DELIVERY DEVICE | Massachusetts Institute of Technology (US) | 2011-10-05 | — | — | EP | claimed |
| WO-2010068281-A2 | CONTACT LENS DRUG DELIVERY DEVICE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-06-17 | — | — | WO | claimed |
| WO-2024146964-A1 | METHOD OF PREPARING MICROPARTICLES, PHARMACEUTICAL POLYMERIC COMPOSITIONS, ACTIVE INGREDIENT DELIVERY MEDICAL DEVICE AND IMPLANT | BODMEIER ROLAND (DE) | 2024-07-11 | — | — | WO | disclosed |
| US-20230381016-A1 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | Sydnexis, Inc. | 2023-11-30 | — | — | US | disclosed |
| US-20220125791-A1 | NOVEL DEVICES | INTRA-CELLULAR THERAPIES, INC. (US) | 2022-04-28 | — | — | US | disclosed |
| US-20200345542-A1 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | Sydnexis, Inc. | 2020-11-05 | — | — | US | disclosed |
| EP-3713530-A1 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | Sydnexis, Inc. (US) | 2020-09-30 | — | — | EP | disclosed |
| WO-2020160037-A1 | NOVEL DEVICES | INTRA-CELLULAR THERAPIES, INC. (US) | 2020-08-06 | — | — | WO | disclosed |
| WO-2019104191-A1 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | Sydnexis, Inc. (US) | 2019-05-31 | — | — | WO | disclosed |
| WO-2010068281-A2 | CONTACT LENS DRUG DELIVERY DEVICE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-06-17 | — | — | WO | disclosed |
| US-20100057039-A1 | DEVICES AND SYSTEMS FOR LOCAL DELIVERY OF INOTROPIC AGENTS TO THE EPICARDIUM | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-03-04 | — | — | US | disclosed |
| EP-0689624-B1 | METHOD AND APPARATUS FOR FORMING PREFABRICATED SELF-FORMING SELF-ADHERING PULL BOW AND PULL BOW FORMED THEREBY | MINNESOTA MINING & MFG (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5628846-A | Method and apparatus for forming prefabricated self-forming self-adhering pull bow and pull bow formed thereby | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0689624-A1 | METHOD AND APPARATUS FOR FORMING PREFABRICATED SELF-FORMING SELF-ADHERING PULL BOW AND PULL BOW FORMED THEREBY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-01-03 | — | — | EP | disclosed |
| US-5468523-A | Method and apparatus for forming prefabricated self-forming self-adhering pull bow and pull bow formed thereby | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-11-21 | — | — | US | disclosed |
| WO-1994021850-A1 | METHOD AND APPARATUS FOR FORMING PREFABRICATED SELF-FORMING SELF-ADHERING PULL BOW AND PULL BOW FORMED THEREBY | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220125791-A1 | NOVEL DEVICES | PDE6A, PDE6C, PDE3A | LMNA 2823/4885HSD17B10 915/4885ALOX15 2735/4885 |
| US-20200345542-A1 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | CHRM3, CHRM2, CHRM4 | LMNA 1318/4885HSD17B10 2202/4885ALOX15 1114/4885 |
| US-20230381016-A1 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | CHRM3, CHRM2, CHRM4 | LMNA 1318/4885HSD17B10 2202/4885ALOX15 1114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.